首页 | 本学科首页   官方微博 | 高级检索  
检索        

培美曲塞二钠联合卡铂治疗非小细胞型肺癌的临床分析
引用本文:张建伟,张宏艳,亢玺刚,张侠,于忠和.培美曲塞二钠联合卡铂治疗非小细胞型肺癌的临床分析[J].中国医药导刊,2012,14(6):1054+1056.
作者姓名:张建伟  张宏艳  亢玺刚  张侠  于忠和
作者单位:北京军区总医院肿瘤科,北京,100700
摘    要:目的:探讨培美曲塞二钠联合卡铂治疗非小细胞型肺癌的临床疗效。方法:回顾性分析80例非小细胞型肺癌患者临床资料,依据治疗方式不同分为对照组30例和观察组(培美曲塞二钠联合卡铂治疗组)50例。结果:观察组临床治疗总缓解率高于对照组,不良反应发生率低于对照组,P<0.05,差异有统计学意义。结论:美曲塞二钠联合卡铂治疗非小细胞型肺癌临床疗效明显,不良反应少。

关 键 词:培美曲塞二钠  卡铂  非小细胞型肺癌

The Clinical Analyze of Curing Non Small Cell Lung Cancer by ALIMTA Combined with Carboplatin
Institution:Zhang Jian-wei,Zhang Hong-yan,Kang Xi-gang,et al.(The general Hospital of Beijing Military Region tumor branch,Beijing 100700,China)
Abstract:Objective:To approach clinical curative effect.Methods:To analyze clinical data of 80 cases Non small cell lung cancer,which were to be divided into control group 30 cases and detection group(ALIMTA combined with carboplatin curing group)50 cases.Results:The total remission rate of detection group were higher than control group,incidence of adverse reactions was lower than control group,P<0.05,the difference were statistical significance.Conclusion:The clinical curative effect of curing Non small cell lung cancer by ALIMTA combined with carboplatin,the adverse reaction was little.
Keywords:ALIMTA  Carboplatin  Lung cancer  Non small cell lung cancer
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号